Your browser doesn't support javascript.
loading
Dark Classics in Chemical Neuroscience: Mescaline.
Cassels, Bruce K; Sáez-Briones, Patricio.
Afiliação
  • Cassels BK; Chemobiodynamics Laboratory, Department of Chemistry, Faculty of Sciences , University of Chile , Santiago 7900003 , Chile.
  • Sáez-Briones P; Laboratory of Neuropharmacology and Behavior, School of Medicine, Faculty of Medical Sciences , Universidad de Santiago de Chile , Santiago 9170022 , Chile.
ACS Chem Neurosci ; 9(10): 2448-2458, 2018 10 17.
Article em En | MEDLINE | ID: mdl-29847089
Archeological studies in the United States, Mexico, and Peru suggest that mescaline, as a cactus constituent, has been used for more than 6000 years. Although it is a widespread cactus alkaloid, it is present in high concentrations in few species, notably the North American peyote ( Lophophora williamsii) and the South American wachuma ( Trichocereus pachanoi, T. peruvianus, and T. bridgesii). Spanish 16th century chroniclers considered these cacti "diabolic", leading to their prohibition, but their use persisted to our days and has been spreading for the last 150 years. In the late 1800s, peyote attracted scientific attention; mescaline was isolated, and its role in the psychedelic effects of peyote tops or "mescal buttons" was demonstrated. Its structure was established by synthesis in 1929, and alternative routes were developed, providing larger amounts for pharmacological and biosynthetic research. Although its effects are attributed mainly to its action as a 5-HT2A serotonin receptor agonist, mescaline binds in a similar concentration range to 5-HT1A and α2A receptors. It is largely excreted unchanged in human urine, and its metabolic products are apparently unrelated to its psychedelic properties. Its low potency is probably responsible for its relative neglect by recreational substance users, as the successful search for structure-activity relationships in the hallucinogen field focused largely on finding more potent analogues. Renewed interest in the possible therapeutic applications of psychedelic drugs may hopefully lead to novel insights regarding the commonalities and differences between the actions of individual classic hallucinogens.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alucinógenos / Mescalina Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Chile País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alucinógenos / Mescalina Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Chile País de publicação: Estados Unidos